Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease
- PMID: 16596254
Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease
Abstract
Myosins of class II constitute part of a superfamily of several classes of proteins expressed in almost all eukaryotic cell types. Differences in the heavy chains produce three isoforms of class II non-muscle myosins (A, B and C), which are widely distributed in most tissues and thought to be components of the cell motor systems, although specific functional roles are largely unknown. In particular, it is still a matter of debate whether they interact and have overlapping or distinct functions. This argument is relevant not only to cell physiology, but also to human pathology since mutations of the MYH9 gene encoding non-muscle myosin heavy chain II A (NMMHC-A) cause MYH9-related disease (MYH9-RD), an autosomal dominant disorder characterized by platelet macrocytosis, thrombocytopenia and leukocyte inclusions, variably associated with sensorineural hearing loss, cataracts and/or glomerulonephritis. In this study, we report the results of yeast two-hybrid screening showing that the C-terminals of NMMHC-A and -B interact. This interaction was confirmed by immunoprecipitation in transfected COS-7 cells and in skin fibroblasts naturally expressing both isoforms. Moreover, our immunomorphological study revealed that isoforms A and B co-localize in fibroblasts, erythroblasts and kidney cells. These results suggest that isoforms A and B are strictly related molecules and support the hypothesis that their interrelationship could be involved both in the variability of clinical phenotype and selectivity of tissue damage of MYH9-RD.
Similar articles
-
Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.Clin Chim Acta. 2006 Nov;373(1-2):49-54. doi: 10.1016/j.cca.2006.04.027. Epub 2006 May 16. Clin Chim Acta. 2006. PMID: 16806139
-
[Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].Rinsho Byori. 2009 Apr;57(4):365-70. Rinsho Byori. 2009. PMID: 19489439 Review. Japanese.
-
Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.Eur J Haematol. 2007 Mar;78(3):220-6. doi: 10.1111/j.1600-0609.2006.00806.x. Epub 2007 Jan 16. Eur J Haematol. 2007. PMID: 17241369
-
[Expression and function of non-muscle myosin-IIA in Fechtner syndrome].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Aug;16(4):871-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18718080 Chinese.
-
MYH9-related platelet disorders.Semin Thromb Hemost. 2009 Mar;35(2):189-203. doi: 10.1055/s-0029-1220327. Epub 2009 Apr 30. Semin Thromb Hemost. 2009. PMID: 19408192 Review.
Cited by
-
Unveiling the enigmatic role of MYH9 in tumor biology: a comprehensive review.Cell Commun Signal. 2024 Aug 27;22(1):417. doi: 10.1186/s12964-024-01781-w. Cell Commun Signal. 2024. PMID: 39192336 Free PMC article. Review.
-
Endogenous species of mammalian nonmuscle myosin IIA and IIB include activated monomers and heteropolymers.Curr Biol. 2014 Sep 8;24(17):1958-68. doi: 10.1016/j.cub.2014.07.070. Epub 2014 Aug 14. Curr Biol. 2014. PMID: 25131674 Free PMC article.
-
Genetic contribution and associated pathophysiology in end-stage renal disease.Appl Clin Genet. 2010 Aug 5;3:65-84. doi: 10.2147/tacg.s7330. Print 2010. Appl Clin Genet. 2010. PMID: 23776353 Free PMC article.
-
The spectrum of MYH9-associated nephropathy.Clin J Am Soc Nephrol. 2010 Jun;5(6):1107-13. doi: 10.2215/CJN.08721209. Epub 2010 Mar 18. Clin J Am Soc Nephrol. 2010. PMID: 20299374 Free PMC article. Review.
-
Enucleation of human erythroblasts involves non-muscle myosin IIB.Blood. 2012 Jan 26;119(4):1036-44. doi: 10.1182/blood-2011-06-361907. Epub 2011 Nov 2. Blood. 2012. PMID: 22049517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous